EUVIMEDScopri EUVIMED
Open access · CC BY-NC 4.0

Prenatal screening for neural tube defects: from maternal serum alpha-fetoprotein to ultrasonography

Gwang Jun Kim, Ji Su Seong, Jin A Oh

Obstetrics & Gynecology Science · 2023-01-15 · 66 (1) · 1-10

DOI: 10.5468/ogs.22263 ↗

At a glance

Journal article in Obstetrics & Gynecology Science, published on 2023-01-15. Written by Gwang Jun Kim and 2 co-authors. Institution: Department of Obstetrics and Gynecology, Chung-Ang University College of Medicine, Seoul, Korea. Cited 13 times so far (Crossref); 42 references. The full text is freely available (open access, CC BY-NC 4.0).

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

The two main screening tests during pregnancy are those for chromosomal abnormalities and neural tube defects (NTDs). In particular, for NTDs, measurement of maternal serum alpha-fetoprotein (MSAFP) levels early in the second trimester (15-18 weeks of gestation) has been considered the gold standard screening test for the past 4 decades. However, with remarkable technological advancements and the widespread use of ultrasound during those periods, mid-trimester ultrasonography has gradually replaced the role of measuring MSAFP levels as a screening method for NTDs. This change was initiated more about 10 years ago in some countries, which have issued national guidelines to use mid-trimester ultrasonography instead of measuring MSAFP levels as a prenatal screening method for NTDs. However, no significant changes have occurred in Korea, where second-trimester ultrasonography is routinely performed with high-quality equipment. We aimed to provide information regarding the importance of changing the screening method for NTDs from MSAFP measurement to ultrasonography, and to detail methods of implementing mid-trimester ultrasonography for screening purposes. We also share our experience of operating a prenatal diagnostic program for NTDs without using MSAFP for more than 15 years.

Subjects

Author keywords

Alpha-fetoproteinNeural tube defectsUltrasonography

Authors and institutions

  • Department of Obstetrics and Gynecology, Chung-Ang University College of Medicine, Seoul, Korea.
  • Chung-Ang University Gwangmyeong Hospital, Gwangmyeong, Korea.

Cite

APA

Kim, G. J., Seong, J. S., & Oh, J. A. (2023). Prenatal screening for neural tube defects: from maternal serum alpha-fetoprotein to ultrasonography. Obstetrics & Gynecology Science, 66(1), 1-10. https://doi.org/10.5468/ogs.22263

Vancouver

Kim GJ, Seong JS, Oh JA. Prenatal screening for neural tube defects: from maternal serum alpha-fetoprotein to ultrasonography. Obstetrics & Gynecology Science. 2023;66(1):1-10. doi:10.5468/ogs.22263

BibTeX
@article{Kim2023,
  author = {Kim, Gwang Jun and Seong, Ji Su and Oh, Jin A},
  title = {Prenatal screening for neural tube defects: from maternal serum alpha-fetoprotein to ultrasonography},
  journal = {Obstetrics & Gynecology Science},
  year = {2023},
  volume = {66},
  number = {1},
  pages = {1--10},
  doi = {10.5468/ogs.22263}
}
Start for free →